logo
logo

Mosaic Biosciences Secures Financing From Telegraph Hill Partners To Support Commercial Growth And Expand Drug Discovery Capabilities And Services

Jun 14, 2022about 3 years ago
BoulderBiotechnology

Description

Mosaic Biosciences (“Mosaic” or “the Company”), a protein and antibody discovery company that helps its partners identify next-generation therapies for the prevention and treatment of disease. announced the closing of a $11.4 million financing led by Telegraph Hill Partners (“THP”), a life science venture capital and growth equity firm based in San Francisco, CA. Dan Mitchell, a Boulder-based venture capitalist, also participated in the financing.

Company Information

Company

Mosaic Biosciences

Location

Boulder, Colorado, United States

About

Mosaic is a protein and antibody discovery company that helps its partners identify next-generation therapies for the prevention and treatment of disease. Mosaic teams provide comprehensive, end-to-end discovery services, including program assessment and strategy development; program management; antibody discovery and optimization; protein production, purification, and characterization; protein engineering; biochemical and cellular assay development; formulation, stability and developability studies; bioanalytical (PK and PD) assay development; and clinical candidate-validating pharmacology.

Related People